SREBP1 as a Potential Biomarker Promotes Cell Proliferation and Invasion in Thyroid Cancer
Clinical trial NCT04072731 · COMPLETED
Trial details
- NCT number
- NCT04072731
- Sponsor
- People's Hospital of Zhengzhou University
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-01-16
- Primary completion
- 2017-07-30
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.